X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6538) 6538
Book Review (1322) 1322
Publication (590) 590
Book Chapter (26) 26
Newsletter (25) 25
Conference Proceeding (15) 15
Magazine Article (5) 5
Dissertation (3) 3
Book / eBook (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5757) 5757
animals (4236) 4236
humans (3618) 3618
alzheimer's disease (3342) 3342
alzheimers-disease (2481) 2481
neurosciences (2415) 2415
amyloid beta-peptides - metabolism (2331) 2331
mice (1833) 1833
amyloid beta-peptides - antagonists & inhibitors (1657) 1657
alzheimer disease - metabolism (1610) 1610
rats (1538) 1538
alzheimer disease - drug therapy (1463) 1463
biochemistry & molecular biology (1228) 1228
male (1173) 1173
cells, cultured (984) 984
amyloid beta-peptides - toxicity (907) 907
brain (901) 901
alzheimer disease - pathology (900) 900
neurons - drug effects (895) 895
amyloid precursor protein (860) 860
disease models, animal (807) 807
a-beta (805) 805
oxidative stress (792) 792
neurons - metabolism (785) 785
pharmacology & pharmacy (778) 778
mice, transgenic (773) 773
neurology (728) 728
peptide fragments - metabolism (727) 727
alzheimer’s disease (690) 690
peptide fragments - antagonists & inhibitors (690) 690
alzheimers disease (666) 666
neuroprotective agents - pharmacology (660) 660
brain - metabolism (655) 655
amyloid beta-protein (640) 640
transgenic mice (618) 618
cell biology (614) 614
female (606) 606
proteins (602) 602
amyloid beta-peptides - pharmacology (601) 601
neurons (588) 588
dose-response relationship, drug (585) 585
amyloid beta-protein precursor - metabolism (584) 584
neurodegenerative diseases (582) 582
amyloid precursor protein secretases - antagonists & inhibitors (571) 571
in-vivo (571) 571
peptides (571) 571
alzheimer disease - physiopathology (565) 565
mouse model (565) 565
peptide fragments - toxicity (560) 560
amyloid-beta (556) 556
β-amyloid (540) 540
precursor protein (523) 523
amyloid beta-peptides - chemistry (503) 503
apoptosis (496) 496
amyloid (495) 495
cell survival - drug effects (487) 487
neurodegeneration (486) 486
protein (483) 483
mice, inbred c57bl (481) 481
rats, sprague-dawley (478) 478
chemistry, medicinal (474) 474
peptide fragments - pharmacology (471) 471
alzheimer disease - genetics (468) 468
peptide (461) 461
amyloid precursor protein secretases - metabolism (460) 460
neurotoxicity (458) 458
in-vitro (445) 445
enzyme inhibitors - pharmacology (444) 444
hippocampus - drug effects (435) 435
analysis (428) 428
beta-amyloid (427) 427
long-term potentiation (425) 425
cell line, tumor (422) 422
article (418) 418
amyloid beta-protein precursor - genetics (417) 417
cell line (416) 416
hippocampus - metabolism (402) 402
phosphorylation (398) 398
research (396) 396
brain - drug effects (394) 394
neuroprotection (389) 389
dementia (386) 386
memory (379) 379
rodents (363) 363
inflammation (361) 361
structure-activity relationship (355) 355
rats, wistar (352) 352
pc12 cells (348) 348
tau proteins - metabolism (346) 346
brain - pathology (345) 345
central-nervous-system (341) 341
clinical neurology (338) 338
amyloid-beta-peptide (337) 337
alzheimer disease (336) 336
neurons - pathology (333) 333
pathology (333) 333
expression (330) 330
activation (324) 324
hippocampus (321) 321
multidisciplinary sciences (311) 311
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6480) 6480
Chinese (38) 38
Japanese (29) 29
Russian (12) 12
German (11) 11
French (5) 5
Spanish (2) 2
Danish (1) 1
Hungarian (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2016, Volume 537, Issue 7618, pp. 50 - 56
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Apolipoproteins | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article